Characterization of a new oral antiarrhythmic drug, flecainide (R818)-Reference-Cited by-同舟云学术

Characterization of a new oral antiarrhythmic drug, flecainide (R818)

Published:1981-08 Issue:4 Volume:73 Page:333-342
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Campbell Cowan J.,Miles Vaughan Williams E.

Publisher

Elsevier BV

Subject

Pharmacology

Reference30 articles.

1. The effect on experimental cardiac arrhythmias of a new anticonvulsant agent, Kö 1173, and its comparison with phenytoin and procainamide;Allen;Br. J. Pharmacol.,1970

2. Clinical electrophysiologic effects of tocainide;Anderson;Circulation,1978

3. The effects on cardiac muscle and nerve of a fluorinated decahydroquinoline derivative, L7810, rapidly absorbed after oral administration;Bagwell;Brit. J. Pharmacol.,1973

4. Anti-arrhythmic drugs: electrophysiological actions;Bassett;Annu. Rev. Pharmacol.,1971

5. The sinus node;Bonke,1978

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option;Frontiers in Pharmacology;2021-03-04

2. Use of Flecainide for the Treatment of Atrial Fibrillation;The American Journal of Cardiology;2020-04

3. Class I antiarrhythmic drugs produced a spinal anesthetic effect in rats;Neuroscience Letters;2011-11

4. Intravenous Flecainide in the Management of Acute Supraventricular Tachyarrhythmias*;Journal of Cardiovascular Electrophysiology;2008-06-28

5. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine;British Journal of Pharmacology;2002-07